Clinical trial
The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)
NCT06128096 is registered in ClinicalTrials.gov with Clinical Research Centre, Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac Function in T2DM Patients With CAD (EpiCAD)
- Lead sponsor
- Clinical Research Centre, Malaysia
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- June 1, 2022
- Completion date
- December 31, 2024
- Enrollment
- 360 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.